(+)-Longifolene, 90%, 250mg

Recipiente de cristalización ROTILABO® sin pico, 100 ml, 70 mm, 10 Unidad(es)

o-Cymene, 98%, 1g

2,2,3,3-Tetrafluoro-2,3-dihydro-1,4-benzodioxine, 98%, 250mg

3,6-Diphenylpyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 95.0%, 5g

tert-Butyl 4-(4-bromo-3-(difluoromethyl)-1H-pyrazol-1-yl)piperidine-1-carboxylate, 95.0%, 250mg

Ethyl 2-(3-(trifluoromethyl)phenyl)thiazole-4-carboxylate, 95.0%, 5g

2-Fluoro-4-methoxybenzenesulfonyl chloride, 95.0%, 250mg

6-Bromopyridazine-3-carbonitrile, 98%, 250mg

Columna HPLC NUCLEODUR® C8 Gravedad 3 µm, 150 mm, 4 mm, 1 Pieza(s)

(5-AMINO-2-(METHOXYCARBONYL)PYRIDIN-4-YL)BORONIC ACID PINACOL ESTER, 95.0%, 500mg

(4-CHLORO-THIAZOL-2-YL)ACETIC ACID, 95.0%, 10g

Methyl 3-(dimethoxymethyl)picolinate, 95.0%, 1g